PT2661280T - Emulsões o/a compreendendo alcanos semifluorados - Google Patents
Emulsões o/a compreendendo alcanos semifluoradosInfo
- Publication number
- PT2661280T PT2661280T PT12700455T PT12700455T PT2661280T PT 2661280 T PT2661280 T PT 2661280T PT 12700455 T PT12700455 T PT 12700455T PT 12700455 T PT12700455 T PT 12700455T PT 2661280 T PT2661280 T PT 2661280T
- Authority
- PT
- Portugal
- Prior art keywords
- emulsions
- semifluorinated alkanes
- semifluorinated
- alkanes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11150064 | 2011-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2661280T true PT2661280T (pt) | 2019-02-25 |
Family
ID=43978091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT12700455T PT2661280T (pt) | 2011-01-04 | 2012-01-03 | Emulsões o/a compreendendo alcanos semifluorados |
| PT171597883T PT3202421T (pt) | 2011-01-04 | 2012-01-03 | Emulsões de o/a que compreendem alcanos semifluorados |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT171597883T PT3202421T (pt) | 2011-01-04 | 2012-01-03 | Emulsões de o/a que compreendem alcanos semifluorados |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US20140004197A1 (pt) |
| EP (2) | EP2661280B1 (pt) |
| JP (1) | JP6073244B2 (pt) |
| KR (1) | KR101910213B1 (pt) |
| CN (1) | CN103313729B (pt) |
| AU (1) | AU2012204932B2 (pt) |
| BR (1) | BR112013016661B1 (pt) |
| CA (1) | CA2819988C (pt) |
| DK (2) | DK2661280T3 (pt) |
| ES (2) | ES2711760T3 (pt) |
| MX (1) | MX353154B (pt) |
| PL (2) | PL3202421T3 (pt) |
| PT (2) | PT2661280T (pt) |
| TR (2) | TR201808752T4 (pt) |
| WO (1) | WO2012093113A1 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101656121B1 (ko) | 2010-03-17 | 2016-09-08 | 노바리크 게엠베하 | 안압 증가를 치료하기 위한 약학 조성물 |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| KR20170122282A (ko) * | 2011-05-25 | 2017-11-03 | 노바리크 게엠베하 | 부분불소화된 알칸에 기초된 국소 제약학적 조성물 |
| AU2012260788B2 (en) | 2011-05-25 | 2017-01-19 | Dermaliq Therapeutics, Inc. | Pharmaceutical composition for administration to nails |
| JP6084987B2 (ja) | 2012-01-23 | 2017-02-22 | ノバリック ゲーエムベーハー | セミフッ素化アルカンに基づく安定化タンパク質組成物 |
| AU2013314303B2 (en) | 2012-09-12 | 2018-01-18 | Novaliq Gmbh | Semifluorinated alkane compositions |
| AU2013314370B2 (en) | 2012-09-12 | 2017-11-30 | Novaliq Gmbh | Compositions comprising mixtures of semifluorinated alkanes |
| GB2511028A (en) * | 2012-12-18 | 2014-08-27 | Univ Manchester Metropolitan | Nano emulsions, methods of forming the same and uses thereof |
| EP2783703A1 (en) * | 2013-03-25 | 2014-10-01 | B. Braun Melsungen AG | Semifluorocarbon compound containing contrast agent |
| PT3024484T (pt) | 2013-07-23 | 2018-10-24 | Novaliq Gmbh | Composições de anticorpo estabilizadas |
| KR20160145558A (ko) * | 2014-03-03 | 2016-12-20 | 앙코르 비전, 인코포레이티드 | 리포산 콜린 에스테르 조성물 및 사용 방법 |
| DK3722274T3 (da) | 2015-09-30 | 2023-09-11 | Novaliq Gmbh | 2-perfluorbutylpentan til oftalmisk indgivelse |
| ES2743502T3 (es) | 2015-09-30 | 2020-02-19 | Novaliq Gmbh | Compuestos semifluorados y sus composiciones |
| WO2017220625A1 (en) | 2016-06-23 | 2017-12-28 | Novaliq Gmbh | Topical administration method |
| PL3515420T3 (pl) | 2016-09-22 | 2024-04-08 | Novaliq Gmbh | Kompozycje farmaceutyczne do zastosowania w terapii zapalenia brzegów powiek |
| EP3515467B1 (en) | 2016-09-23 | 2023-11-29 | Novaliq GmbH | Ophthalmic compositions comprising ciclosporin |
| WO2018193093A1 (en) | 2017-04-21 | 2018-10-25 | Novaliq Gmbh | Iodine compositions |
| WO2018202835A1 (en) | 2017-05-05 | 2018-11-08 | Novaliq Gmbh | Process for the production of semifluorinated alkanes |
| CN110650734A (zh) | 2017-05-12 | 2020-01-03 | 诺瓦利克有限责任公司 | 治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物 |
| JP2020535156A (ja) | 2017-09-27 | 2020-12-03 | ノバリック ゲーエムベーハー | 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物 |
| US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
| AU2019228119A1 (en) | 2018-03-02 | 2020-09-10 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
| CA3111870C (en) | 2018-09-27 | 2022-04-12 | Novaliq Gmbh | Topical sunscreen formulation |
| AU2019358249B2 (en) | 2018-10-12 | 2024-02-22 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| US11628178B2 (en) | 2019-03-26 | 2023-04-18 | Epalex Corporation | Fospropofol methods and compositions |
| US11547714B2 (en) | 2020-02-05 | 2023-01-10 | Epalex Corporation | Fospropofol salts, methods and compositions |
| US11478490B1 (en) | 2021-03-30 | 2022-10-25 | Epalex Corporation | Fospropofol formulations |
| US11439653B1 (en) | 2021-03-30 | 2022-09-13 | Epalex Corporation | Fospropofol formulations |
| EP3912621A1 (en) * | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Propofol for diagnosis of primary headache |
| FR3112475B1 (fr) | 2020-07-20 | 2023-11-10 | Naos Inst Of Life Science | formulation écobiologique, compatible avec la vie cellulaire, utilisable dans les domaines cosmétiques, dermopharmaceutiques ou vétérinaires |
| AU2021426502A1 (en) * | 2021-02-05 | 2023-08-17 | Epalex Corporation | Fospropofol methods and compositions |
| DE102021005495A1 (de) | 2021-11-06 | 2023-05-11 | Kocher-Plastik Maschinenbau Gmbh | Trennvorrichtung |
| DE102021005494A1 (de) | 2021-11-06 | 2023-05-11 | Kocher-Plastik Maschinenbau Gmbh | Trennvorrichtung |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5077036A (en) * | 1986-01-14 | 1991-12-31 | Alliance Pharmaceutical Corp. | Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid |
| FR2679150A1 (fr) * | 1991-07-17 | 1993-01-22 | Atta | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. |
| DE19536504C2 (de) * | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| DE19709704C2 (de) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
| AU759641B2 (en) * | 1998-08-19 | 2003-04-17 | Skyepharma Canada Inc. | Injectable aqueous dispersions of propofol |
| US6140374A (en) | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
| EP1124416A1 (en) | 1999-03-15 | 2001-08-22 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| US6177477B1 (en) * | 1999-03-24 | 2001-01-23 | American Home Products Corporation | Propofol formulation containing TRIS |
| US6399087B1 (en) * | 2000-12-20 | 2002-06-04 | Amphastar Pharmaceuticals, Inc. | Propofol formulation with enhanced microbial inhibition |
| CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
| WO2005051305A2 (en) * | 2003-11-19 | 2005-06-09 | Barnes-Jewish Hospital | Enhanced drug delivery |
| JP2009503059A (ja) | 2005-08-05 | 2009-01-29 | ブハラット セルムズ アンド ヴァクシンズ リミテッド | 防腐効果を有する静脈プロポフォールエマルジョン組成物 |
| TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| EP2110126B9 (de) | 2008-04-18 | 2012-09-19 | Novaliq GmbH | Inhalative und instillative Verwendung von semifluorierten Alkanen als Wirkstoffträger im intrapulmonalen Bereich |
-
2012
- 2012-01-03 PL PL17159788T patent/PL3202421T3/pl unknown
- 2012-01-03 DK DK12700455.4T patent/DK2661280T3/en active
- 2012-01-03 JP JP2013546732A patent/JP6073244B2/ja not_active Expired - Fee Related
- 2012-01-03 AU AU2012204932A patent/AU2012204932B2/en active Active
- 2012-01-03 ES ES12700455T patent/ES2711760T3/es active Active
- 2012-01-03 BR BR112013016661-4A patent/BR112013016661B1/pt active IP Right Grant
- 2012-01-03 MX MX2013007807A patent/MX353154B/es active IP Right Grant
- 2012-01-03 KR KR1020137018703A patent/KR101910213B1/ko active IP Right Grant
- 2012-01-03 PT PT12700455T patent/PT2661280T/pt unknown
- 2012-01-03 US US13/978,334 patent/US20140004197A1/en not_active Abandoned
- 2012-01-03 CN CN201280004613.1A patent/CN103313729B/zh active Active
- 2012-01-03 EP EP12700455.4A patent/EP2661280B1/en active Active
- 2012-01-03 PT PT171597883T patent/PT3202421T/pt unknown
- 2012-01-03 DK DK17159788.3T patent/DK3202421T3/en active
- 2012-01-03 EP EP17159788.3A patent/EP3202421B1/en active Active
- 2012-01-03 TR TR2018/08752T patent/TR201808752T4/tr unknown
- 2012-01-03 TR TR2019/01309T patent/TR201901309T4/tr unknown
- 2012-01-03 PL PL12700455T patent/PL2661280T3/pl unknown
- 2012-01-03 ES ES17159788.3T patent/ES2675242T3/es active Active
- 2012-01-03 CA CA2819988A patent/CA2819988C/en active Active
- 2012-01-03 WO PCT/EP2012/050043 patent/WO2012093113A1/en active Application Filing
-
2017
- 2017-04-19 US US15/491,521 patent/US20170216204A1/en not_active Abandoned
-
2019
- 2019-01-28 US US16/259,037 patent/US20190224123A1/en not_active Abandoned
-
2020
- 2020-04-30 US US16/863,918 patent/US20200360285A1/en not_active Abandoned
-
2022
- 2022-12-23 US US18/146,306 patent/US20230139672A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2661280T (pt) | Emulsões o/a compreendendo alcanos semifluorados | |
| HK1247116A1 (zh) | 基於半氟化烷烴類的外用藥物組合物 | |
| AU338052S (en) | Goggles | |
| PL2806886T3 (pl) | Stabilizowane kompozycje białkowe oparte na semifluorowanych alkanach | |
| ZA201403090B (en) | Tropicalizing agent | |
| EP2724729A4 (en) | APOPTOSIS INDUCING AGENT | |
| GB201111438D0 (en) | Formulation | |
| EP3701800C0 (en) | USE | |
| ZA201309221B (en) | Formulation | |
| HK1211858A1 (en) | Diclofenac composition | |
| GB201121705D0 (en) | Multiple use footwear | |
| ZA201402456B (en) | Formulation | |
| EP2787050A4 (en) | LECITHIN-Organogel formers | |
| TWI562734B (en) | Sense-improving agent | |
| EP2687212A4 (en) | DRUG AGENT | |
| EP2764870A4 (en) | MEANS FOR IMPROVED SENSUAL ASSESSMENT | |
| EP2863894A4 (en) | fenofibrate | |
| EP2863890A4 (en) | FORMULATION OF FENOFIBRATE | |
| GB201106958D0 (en) | Formulation | |
| GB201119383D0 (en) | Rara | |
| GB201102289D0 (en) | New use | |
| GB2483187B (en) | Goggles | |
| GB201104284D0 (en) | Formulation | |
| GB201119436D0 (en) | Use | |
| PL396249A1 (pl) | Organizer endodontyczny |